Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Star
1718.7000 -3.60 (-0.21%)
NSE Nov 20, 2026 15:31 PM
Volume: 241.9K
 

1718.70
-0.21%
Motilal Oswal
Rubicon Research (Rubicon) aims to make inroads into the central nervous system (CNS) therapy in India’s branded market (DF) through Arinna Lifescience (Arinna).
Rubicon Research Ltd. has an average target of 1915.00 from 1 broker.
More from Rubicon Research …
All earning calls
Investor presentations from Rubicon Research …
All investor presentations